CapIQ

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-08-03.

Consensus Tape

Consensus trimmed Copart's forward numbers over the past six months — FY2027 revenue is down about 5% and FY2028 down 6% from where they sat in February — but the cuts have essentially stopped over the most recent quarter. The company keeps clearing EPS: five straight quarterly beats into FY2026, even as revenue ran light of consensus in four of the last seven quarters. Outer-year coverage, FY2028 and FY2029, rests on a handful of analysts.

Source: derived from vendor data.

Consensus cut forward estimates ~5% over six months, then stopped

The forward tape moved one way this year: down. FY2027 revenue consensus fell 4.9% from its February level, and FY2028 revenue fell 6.4%; on the earnings line, FY2027 EPS came down 6.6% and FY2028 EPS 3.3%. Almost all of that happened in the first half of the window — over the most recent quarter FY2027 revenue and EPS are within 0.2% of today, and FY2028 has not moved at all in the past month. The shape is a downgrade cycle that has flattened, not one still deteriorating.

Source: derived from vendor data.

That both revenue and EPS were cut together points to a demand-side markdown rather than a margin reset; the tape carries the direction and magnitude, not the cause.

Copart keeps beating on EPS while revenue runs light

The beat/miss record splits by line. Normalized EPS has topped consensus in six of the last seven quarters — five in a row from FY2025 Q1 through FY2026 Q1, with a standout 13.3% beat in FY2025 Q4 — interrupted only by a single-quarter miss in FY2026 Q2. Revenue tells a softer story: it missed consensus in four of the last seven quarters, including a run of four straight small misses. Beating earnings while revenue lands short is a margin-quality signal, and it sits alongside the revenue-led downgrades above.

Source: derived from vendor data.

A flat FY2026, then reacceleration through FY2029

The consensus trajectory is not a straight line. Revenue and EBITDA are seen essentially flat in FY2026 — revenue consensus of $4,645M is within half a percent of FY2025 — before growth resumes: revenue +3.9% in FY2027, +8.4% in FY2028 and +7.2% in FY2029, a roughly 4.7% four-year CAGR. EPS is expected to compound a little faster, from $1.55 in FY2025 to $1.97 in FY2029, about a 6% CAGR, helped by the below-the-line leverage the beat pattern already hints at.

Source: derived from vendor data.

Coverage thins to a handful of analysts by FY2028

Confidence in the outer years should be read against how few analysts stand behind them. Revenue and EPS carry 11 to 13 estimates through FY2027, then drop to four contributors in FY2028 and two in FY2029; EBITDA is thinner still, at three estimates in FY2028 and a single one in FY2029. Even where coverage is deep, FY2027 EPS spans $1.55 to $1.78 across 13 analysts — a genuinely wide disagreement on the near-forward earnings line, not just outer-year noise.

Source: derived from vendor data.

The street: mildly positive, with targets spanning 2x

Positioning is constructive but not crowded. Of 13 ratings, seven are positive (five buy, two outperform), five are hold and one is negative. Price targets, from 10 estimates, average $40.30 with a $41 median, but the range is wide — a low of $26 against a high of $55, a 2.1x spread that signals real disagreement on value. This feed carries no current share price, so no upside or downside to it is implied here.

Source: derived from vendor data.

For driver-level broker models and segment detail, see the Visible Alpha tab.